Our results revealed that both mRNA and protein levels of NTMT1 were markedly increased in various types of tumors, and high expression of NTMT1 was closely correlated with poor prognosis in ACC, HNSCC, AML, READ, and UVM. This evidence concerns the gene NTMT1 and acute myeloid leukemia.